← Leaderboards
Yun Wei
Massachusetts General Hospital
$605,400
Attributed
$605,400
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2023–25$250K$187.5K$125K$62.5K$0
'23
'24
'25
Funding mix
By agency
NIH$605,400 · 2
By mechanism
K99$356,400 · 1
R00$249,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Ben Z Stanger$14,778,829
- Jodie L Babitt$8,318,929
- David Michael Langenau$26,574,494
- Rakesh K. Jain$48,476,214
- Lance L Munn$15,934,149
Others in their field
Other Rising Stars on “Cost”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
CostAffectBar CodesAftercareCancer CellAnimal ModelCatalytic DomainCell CycleCell Differentiation ProcessBindingCell LineCell LineageCell ProliferationCellsChemotherapyChemotherapy And/Or RadiationChildhood SarcomaChildhood Soft Tissue SarcomaChromatinClinicCollaborationsCell KillingComplexCyclophosphamide
Grant awards (3)
Chromatin regulators of stemness and therapy resistance in rhabdomyosarcoma$249,000
R00 · FY2025 · CA · contact PI
Chromatin regulators of stemness and therapy resistance in rhabdomyosarcoma$178,200
K99 · FY2024 · CA · contact PI
Chromatin regulators of stemness and therapy resistance in rhabdomyosarcoma$178,200
K99 · FY2023 · CA · contact PI